 Jason Weinman
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 26 | 2024 | 2512 | 3.570 |
Why?
| | Radiation Dosage | 5 | 2024 | 154 | 2.050 |
Why?
| | Phantoms, Imaging | 2 | 2024 | 137 | 1.680 |
Why?
| | Lung Diseases, Interstitial | 9 | 2024 | 610 | 1.610 |
Why?
| | Glycogen Storage Disease | 4 | 2021 | 19 | 1.080 |
Why?
| | Hypertension, Pulmonary | 7 | 2024 | 1894 | 0.990 |
Why?
| | Radiography, Abdominal | 1 | 2024 | 46 | 0.860 |
Why?
| | Lung Diseases | 4 | 2022 | 741 | 0.790 |
Why?
| | Bronchiolitis Obliterans | 2 | 2021 | 68 | 0.740 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2021 | 44 | 0.710 |
Why?
| | Protein C | 1 | 2021 | 47 | 0.710 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.630 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 15 | 0.630 |
Why?
| | Chorea | 1 | 2019 | 11 | 0.630 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 11 | 0.630 |
Why?
| | Child | 29 | 2024 | 20884 | 0.630 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2019 | 99 | 0.620 |
Why?
| | Pulmonary Eosinophilia | 1 | 2018 | 27 | 0.600 |
Why?
| | Silicosis | 1 | 2018 | 27 | 0.590 |
Why?
| | Head | 1 | 2019 | 96 | 0.580 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 103 | 0.580 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2018 | 97 | 0.570 |
Why?
| | Bronchiolitis | 1 | 2017 | 90 | 0.510 |
Why?
| | Bronchiectasis | 3 | 2024 | 110 | 0.510 |
Why?
| | Infant, Newborn | 12 | 2024 | 5756 | 0.490 |
Why?
| | Spondylolysis | 1 | 2015 | 7 | 0.480 |
Why?
| | Imaging, Three-Dimensional | 2 | 2018 | 528 | 0.470 |
Why?
| | Marijuana Smoking | 1 | 2018 | 247 | 0.470 |
Why?
| | Child, Preschool | 15 | 2024 | 10490 | 0.470 |
Why?
| | Photons | 2 | 2024 | 64 | 0.440 |
Why?
| | Bone Cysts | 1 | 2013 | 9 | 0.410 |
Why?
| | Humans | 49 | 2025 | 129627 | 0.400 |
Why?
| | Infant | 17 | 2025 | 8995 | 0.400 |
Why?
| | Heart Defects, Congenital | 5 | 2023 | 792 | 0.400 |
Why?
| | Biopsy | 4 | 2018 | 1088 | 0.370 |
Why?
| | Computed Tomography Angiography | 2 | 2022 | 115 | 0.360 |
Why?
| | Retrospective Studies | 20 | 2024 | 14522 | 0.360 |
Why?
| | Pediatrics | 1 | 2019 | 1056 | 0.350 |
Why?
| | Lung | 10 | 2024 | 3938 | 0.350 |
Why?
| | Pulmonary Edema | 2 | 2022 | 106 | 0.340 |
Why?
| | Male | 26 | 2025 | 63671 | 0.330 |
Why?
| | Coronary Vessels | 2 | 2022 | 239 | 0.320 |
Why?
| | Altitude Sickness | 2 | 2022 | 141 | 0.310 |
Why?
| | Respiratory Insufficiency | 2 | 2023 | 313 | 0.300 |
Why?
| | Mutation | 4 | 2024 | 3717 | 0.270 |
Why?
| | Brain | 1 | 2019 | 2673 | 0.260 |
Why?
| | Reproducibility of Results | 4 | 2024 | 3080 | 0.250 |
Why?
| | Pulmonary Alveoli | 4 | 2021 | 403 | 0.250 |
Why?
| | Pulmonary Artery | 3 | 2024 | 1097 | 0.250 |
Why?
| | Female | 23 | 2024 | 68735 | 0.250 |
Why?
| | Radiography | 3 | 2018 | 797 | 0.240 |
Why?
| | Submandibular Gland | 1 | 2025 | 19 | 0.240 |
Why?
| | Interleukin-5 | 1 | 2025 | 45 | 0.240 |
Why?
| | Churg-Strauss Syndrome | 1 | 2025 | 25 | 0.240 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2024 | 199 | 0.230 |
Why?
| | Adolescent | 11 | 2025 | 20412 | 0.230 |
Why?
| | Trachea | 3 | 2020 | 226 | 0.220 |
Why?
| | Body Size | 1 | 2024 | 104 | 0.220 |
Why?
| | Tin | 1 | 2023 | 9 | 0.210 |
Why?
| | Stenosis, Pulmonary Vein | 1 | 2023 | 17 | 0.200 |
Why?
| | Pulmonary Atresia | 1 | 2022 | 20 | 0.200 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2025 | 757 | 0.200 |
Why?
| | Sensitivity and Specificity | 2 | 2024 | 1843 | 0.200 |
Why?
| | Abdominal Abscess | 1 | 2022 | 26 | 0.190 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 51 | 0.190 |
Why?
| | Coronary Circulation | 1 | 2022 | 138 | 0.190 |
Why?
| | Pulmonary Veins | 1 | 2023 | 98 | 0.190 |
Why?
| | Social Norms | 1 | 2022 | 24 | 0.190 |
Why?
| | Bronchi | 2 | 2023 | 249 | 0.180 |
Why?
| | Fractures, Bone | 2 | 2017 | 394 | 0.180 |
Why?
| | Pleural Effusion | 1 | 2021 | 52 | 0.180 |
Why?
| | Sexism | 1 | 2022 | 56 | 0.180 |
Why?
| | Stevens-Johnson Syndrome | 1 | 2021 | 38 | 0.180 |
Why?
| | Pulmonary Fibrosis | 1 | 2024 | 385 | 0.180 |
Why?
| | Esophageal Atresia | 1 | 2020 | 24 | 0.170 |
Why?
| | Surface-Active Agents | 1 | 2021 | 84 | 0.170 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2020 | 19 | 0.170 |
Why?
| | Body Surface Area | 1 | 2020 | 33 | 0.170 |
Why?
| | Coronary Angiography | 1 | 2022 | 306 | 0.170 |
Why?
| | Tracheoesophageal Fistula | 1 | 2020 | 33 | 0.170 |
Why?
| | Vasculitis | 1 | 2021 | 65 | 0.170 |
Why?
| | Vaping | 1 | 2021 | 54 | 0.170 |
Why?
| | Joint Diseases | 1 | 2021 | 57 | 0.170 |
Why?
| | Mucolipidoses | 1 | 2020 | 7 | 0.170 |
Why?
| | Hemorrhage | 2 | 2021 | 680 | 0.170 |
Why?
| | Autoimmune Diseases | 1 | 2024 | 427 | 0.170 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2021 | 89 | 0.160 |
Why?
| | Fracture Healing | 2 | 2017 | 75 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2021 | 150 | 0.160 |
Why?
| | Echocardiography | 1 | 2022 | 634 | 0.160 |
Why?
| | Death, Sudden | 1 | 2019 | 24 | 0.160 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2021 | 576 | 0.150 |
Why?
| | Crohn Disease | 1 | 2022 | 217 | 0.150 |
Why?
| | Signal-To-Noise Ratio | 1 | 2019 | 68 | 0.150 |
Why?
| | Lung Injury | 1 | 2021 | 211 | 0.150 |
Why?
| | Altitude | 2 | 2022 | 462 | 0.150 |
Why?
| | Neuroendocrine Cells | 1 | 2018 | 31 | 0.150 |
Why?
| | Bronchioles | 1 | 2018 | 23 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2020 | 240 | 0.140 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2023 | 379 | 0.140 |
Why?
| | Respiration Disorders | 1 | 2018 | 72 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3394 | 0.140 |
Why?
| | Pneumonia, Lipid | 1 | 2017 | 3 | 0.140 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2017 | 19 | 0.140 |
Why?
| | Socioeconomic Factors | 1 | 2022 | 1213 | 0.140 |
Why?
| | Arteriovenous Anastomosis | 1 | 2017 | 13 | 0.140 |
Why?
| | Bronchial Arteries | 1 | 2017 | 12 | 0.140 |
Why?
| | Radiation Exposure | 1 | 2017 | 45 | 0.140 |
Why?
| | Predictive Value of Tests | 1 | 2022 | 1947 | 0.140 |
Why?
| | Airway Obstruction | 1 | 2019 | 152 | 0.140 |
Why?
| | Anti-Asthmatic Agents | 1 | 2021 | 374 | 0.130 |
Why?
| | Birth Injuries | 1 | 2016 | 10 | 0.130 |
Why?
| | Respiratory Function Tests | 1 | 2018 | 581 | 0.130 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2024 | 634 | 0.130 |
Why?
| | Gastrointestinal Diseases | 1 | 2018 | 198 | 0.130 |
Why?
| | Comorbidity | 2 | 2020 | 1547 | 0.130 |
Why?
| | Bone Remodeling | 1 | 2017 | 71 | 0.130 |
Why?
| | Clavicle | 1 | 2016 | 33 | 0.130 |
Why?
| | Heart Rate | 1 | 2020 | 802 | 0.130 |
Why?
| | Upper Extremity | 1 | 2017 | 95 | 0.120 |
Why?
| | Anemia, Sickle Cell | 1 | 2019 | 252 | 0.120 |
Why?
| | Wounds and Injuries | 1 | 2022 | 711 | 0.120 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.120 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.120 |
Why?
| | Down Syndrome | 1 | 2021 | 478 | 0.120 |
Why?
| | Lumbosacral Region | 1 | 2015 | 55 | 0.120 |
Why?
| | Child Abuse | 2 | 2017 | 512 | 0.110 |
Why?
| | Kidney Neoplasms | 1 | 2017 | 348 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1432 | 0.100 |
Why?
| | Humerus | 1 | 2013 | 41 | 0.100 |
Why?
| | Lumbar Vertebrae | 1 | 2015 | 234 | 0.100 |
Why?
| | Lower Extremity | 1 | 2017 | 408 | 0.100 |
Why?
| | Postoperative Care | 1 | 2013 | 241 | 0.090 |
Why?
| | Femur | 1 | 2013 | 243 | 0.090 |
Why?
| | Hypoxia | 1 | 2017 | 1084 | 0.080 |
Why?
| | Bronchoscopy | 2 | 2020 | 216 | 0.080 |
Why?
| | Heart Failure | 1 | 2021 | 2133 | 0.070 |
Why?
| | Cross-Sectional Studies | 4 | 2022 | 5075 | 0.070 |
Why?
| | Asthma | 1 | 2021 | 2225 | 0.070 |
Why?
| | Adult | 3 | 2024 | 35600 | 0.060 |
Why?
| | Prospective Studies | 3 | 2022 | 7135 | 0.050 |
Why?
| | Young Adult | 4 | 2023 | 12455 | 0.050 |
Why?
| | Prognosis | 2 | 2024 | 3774 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 96 | 0.050 |
Why?
| | Pandemics | 2 | 2022 | 1491 | 0.050 |
Why?
| | Fibrin | 1 | 2023 | 68 | 0.050 |
Why?
| | Cellulitis | 1 | 2022 | 49 | 0.050 |
Why?
| | Infliximab | 1 | 2022 | 101 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2022 | 115 | 0.050 |
Why?
| | Necrosis | 1 | 2022 | 232 | 0.050 |
Why?
| | Transforming Growth Factor beta | 1 | 2003 | 460 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2025 | 580 | 0.040 |
Why?
| | Granuloma | 1 | 2021 | 89 | 0.040 |
Why?
| | Ultrasonography | 1 | 2023 | 712 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2003 | 961 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 402 | 0.040 |
Why?
| | Cardiac Catheterization | 1 | 2022 | 520 | 0.040 |
Why?
| | Heart | 1 | 2023 | 641 | 0.040 |
Why?
| | Infant, Premature | 1 | 2023 | 542 | 0.040 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 23 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 324 | 0.040 |
Why?
| | Electric Impedance | 1 | 2018 | 102 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2019 | 300 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2022 | 869 | 0.040 |
Why?
| | Hyperplasia | 1 | 2018 | 175 | 0.040 |
Why?
| | Rare Diseases | 1 | 2018 | 98 | 0.040 |
Why?
| | Macrophage Activation Syndrome | 1 | 2017 | 21 | 0.030 |
Why?
| | Unnecessary Procedures | 1 | 2017 | 48 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1202 | 0.030 |
Why?
| | Bony Callus | 1 | 2016 | 6 | 0.030 |
Why?
| | Arthritis, Juvenile | 1 | 2017 | 53 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2021 | 613 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 226 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2564 | 0.030 |
Why?
| | Observer Variation | 1 | 2016 | 314 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 876 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 524 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2641 | 0.030 |
Why?
| | Colorado | 1 | 2022 | 4404 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2025 | 10219 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3075 | 0.020 |
Why?
| | Chemokines, CXC | 1 | 2003 | 70 | 0.010 |
Why?
| | Peroxidase | 1 | 2003 | 175 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2003 | 326 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2003 | 374 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2003 | 646 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1308 | 0.010 |
Why?
| | Oxygen | 1 | 2003 | 915 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2003 | 2395 | 0.010 |
Why?
| | Neutrophils | 1 | 2003 | 1210 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1366 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2003 | 4084 | 0.010 |
Why?
| | Rats | 1 | 2003 | 5483 | 0.010 |
Why?
| | Animals | 1 | 2003 | 35391 | 0.000 |
Why?
|
|
Weinman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|